U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CS 1003
Preferred Name English
NOFAZINLIMAB
INN  
Official Name English
ANTIBODY CS1003
Common Name English
Nofazinlimab [WHO-DD]
Common Name English
CS-1003
Code English
IMMUNOGLOBULIN G4 (223-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL CS1003 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CS1003 .KAPPA.-CHAIN, DIMER
Common Name English
RECOMBINANT PD-1 MAB CS1003
Common Name English
nofazinlimab [INN]
Common Name English
CS1003
Code English
Code System Code Type Description
FDA UNII
42T48Q7A6O
Created by admin on Wed Apr 02 02:24:48 GMT 2025 , Edited by admin on Wed Apr 02 02:24:48 GMT 2025
PRIMARY
CAS
2377845-98-0
Created by admin on Wed Apr 02 02:24:48 GMT 2025 , Edited by admin on Wed Apr 02 02:24:48 GMT 2025
PRIMARY
INN
11892
Created by admin on Wed Apr 02 02:24:48 GMT 2025 , Edited by admin on Wed Apr 02 02:24:48 GMT 2025
PRIMARY
NCI_THESAURUS
C156726
Created by admin on Wed Apr 02 02:24:48 GMT 2025 , Edited by admin on Wed Apr 02 02:24:48 GMT 2025
PRIMARY
SMS_ID
300000005720
Created by admin on Wed Apr 02 02:24:48 GMT 2025 , Edited by admin on Wed Apr 02 02:24:48 GMT 2025
PRIMARY
ACTIVE MOIETY
NOFAZINLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966